Evidence map›Paper›PMID 26732765›Full record

ArticleLab on a chip2016

A high-efficiency superhydrophobic plasma separator.

Changchun Liu, Shih-Chuan Liao, Jinzhao Song, Michael G Mauk, Xuanwen Li, Gaoxiang Wu, Dengteng Ge, Robert M Greenberg, Shu Yang, Haim H Bau

Open access · greenAbstract read
In one paragraph

Article in Lab on a chip, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 107 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Changchun LiuDepartment of Mechanical Engineering and Applied Mechanics, University of Pennsylvania, 210 Towne Building, 220 South 33rd St, Philadelphia, Pennsylvania 19104-6315, USA. lchangc@seas.upenn.edu.
Shih-Chuan LiaoDepartment of Mechanical Engineering and Applied Mechanics, University of Pennsylvania, 210 Towne Building, 220 South 33rd St, Philadelphia, Pennsylvania 19104-6315, USA. lchangc@seas.upenn.edu and Department of Biomechatronics Engineering, National Pingtung University of Science and Technology, Pingtung 912, Taiwan, Republic of China.
Jinzhao SongDepartment of Mechanical Engineering and Applied Mechanics, University of Pennsylvania, 210 Towne Building, 220 South 33rd St, Philadelphia, Pennsylvania 19104-6315, USA. lchangc@seas.upenn.edu.
Michael G MaukDepartment of Mechanical Engineering and Applied Mechanics, University of Pennsylvania, 210 Towne Building, 220 South 33rd St, Philadelphia, Pennsylvania 19104-6315, USA. lchangc@seas.upenn.edu.
Xuanwen LiInstitute for Translational Medicine and Therapeutics, Perelman School of Medicine, USA.
Gaoxiang WuDepartment of Materials Science and Engineering, 3231 Walnut Street, Philadelphia, PA 19104, USA.
Dengteng GeDepartment of Materials Science and Engineering, 3231 Walnut Street, Philadelphia, PA 19104, USA.
Robert M GreenbergDepartment of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Shu YangDepartment of Materials Science and Engineering, 3231 Walnut Street, Philadelphia, PA 19104, USA.
Haim H BauDepartment of Mechanical Engineering and Applied Mechanics, University of Pennsylvania, 210 Towne Building, 220 South 33rd St, Philadelphia, Pennsylvania 19104-6315, USA. lchangc@seas.upenn.edu.
Philadelphia University · USCalifornia University of Pennsylvania · USUniversity of Pennsylvania · USNational Pingtung University of Science and Technology · TWTranslational Therapeutics (United States) · US

Funding

Virus & Reservoirs CoreP30AI045008 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI ROBERT GROSS · 1999 to 2026
$78.6M
Fully-Integrated, Non-Instrumented Device for Molecular DiagnosticsK25AI099160 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI LIU, CHANGCHUN · 2012 to 2016
$642k
A strategy for point-of-care molecular detection of parasitic helminth infectionsR21AI112713 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI GREENBERG, ROBERT M · 2014 to 2015
$440k
Point of Care Device for Molecular Detection of HIVR41AI104418 · NIAID · AC DIAGNOSTICS, INC. · PI BAU, HAIM H, XIA, JUN Q · 2013 to 2013
$300k
NIAID NIH HHS AI045008NIAID NIH HHS K25 AI099160NIAID NIH HHS K25AI099160NIAID NIH HHS P30 AI045008NIAID NIH HHS R21 AI112713NIAID NIH HHS R21AI112713NIAID NIH HHS R41 AI104418NIAID NIH HHS R41AI104418
6 · The paper itself

Abstract

To meet stringent limit-of-detection specifications for low abundance target molecules, a relatively large volume of plasma is needed for many blood-based clinical diagnostics. Conventional centrifugation methods for plasma separation are not suitable for on-site testing or bedside diagnostics. Here, we report a simple, yet high-efficiency, clamshell-style, superhydrophobic plasma separator that is capable of separating a relatively large volume of plasma from several hundred microliters of whole blood (finger-prick blood volume). The plasma separator consists of a superhydrophobic top cover with a separation membrane and a superhydrophobic bottom substrate. Unlike previously reported membrane-based plasma separators, the separation membrane in our device is positioned at the top of the sandwiched whole blood film to increase the membrane separation capacity and plasma yield. In addition, the device's superhydrophobic characteristics (i) facilitates the formation of well-defined, contracted, thin blood film with a high contact angle; (ii) minimizes biomolecular adhesion to surfaces; (iii) increases blood clotting time; and (iv) reduces blood cell hemolysis. The device demonstrated a "blood in-plasma out" capability, consistently extracting 65 ± 21.5 μL of plasma from 200 μL of whole blood in less than 10 min without electrical power. The device was used to separate plasma from Schistosoma mansoni genomic DNA-spiked whole blood with a recovery efficiency of >84.5 ± 25.8%. The S. mansoni genomic DNA in the separated plasma was successfully tested on our custom-made microfluidic chip by using loop mediated isothermal amplification (LAMP) method.

Indexed as

DNA, HelminthMembranes, ArtificialSchistosoma mansoniAnimalsBlood Component RemovalFemaleHumansHydrophobic and Hydrophilic InteractionsMalePlasmaDNA, HelminthMembranes, Artificial

Identifiers

PMID26732765
PMCPMC4729584
OpenAlexW2201285087

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.